ArticleEClinicalMedicine2025
Multimodal machine learning-based marker enables the link between obesity-related indices and future stroke: a prospective cohort study.
Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Associations of triglyceride-glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis.Cardiovascular diabetology · 2026Pooled it
- Efficacy and Safety of Pregabalin and Alpha-Lipoic Acid Combination in Patients With Painful Diabetic Peripheral Neuropathy: A Randomized, Open-Label, Non-Inferiority, Phase IV Clinical Trial and Subgroup Analysis (OPTIMUM Study).Diabetes, obesity & metabolism · 2026Trial
- Current status and future perspectives of platelet function-guided precision antiplatelet therapy for patients with cerebral infarction.Neuroprotection (Chichester, England) · 2026Review
- Mechanisms and integrative machine learning approaches to blood-brain barrier biomarker profiling for personalized ischemic stroke management.Physiological reports · 2026Review
- [A two-stage model for predicting postoperative pulmonary infection in esophageal cancer patients].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026Article
- Changes in Immune-Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort.Annals of clinical and translational neurology · 2026Article
- Comprehensive evaluation of triglyceride glucose index-a body shape index (TyG-ABSI) for incident peripheral artery disease: data-driven phenotyping and machine learning-based risk prediction in the UK Biobank.Cardiovascular diabetology · 2026Article
- Association of the triglyceride-glucose-body mass index with all-cause mortality in critically ill patients with hemorrhagic stroke: a retrospective cohort study from the MIMIC-IV database.Neurosurgical review · 2026Article
- Development and external validation of a composite biomarker-based machine learning model for sarcopenia risk stratification in patients with cardiovascular disease.Frontiers in cardiovascular medicine · 2026Article
- Nonlinear relationship between incidence of new-onset stroke and plasma atherosclerotic index in middle-aged and older adults.Frontiers in neurology · 2025Article
- Frailty prediction in patients with chronic digestive system diseases: based on multi-task learning model.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity is a significant risk factor for stroke. However, body mass index is insufficient in assessing fat distribution and there is a need for a better indicator to predict stroke risk. Additionally, early detection and prognosis prediction for stroke and mortality are crucial for pre-emptive interventions. We examined to evaluate the utility of obesity-related indices in a stacked machine learning (ML) model by developing an in-silico quantitative marker (ISS) to predict stroke risk. Methods: This is a prospective cohort study utilizing data from the China Health and Retirement Longitudinal Study (CHARLS) (2011-2018) and a health examination cohort in China (2017-2024), English Longitudinal Study of Ageing (ELSA) (2004-2014) in the UK. A total of 13,324 participants from CHARLS were included in the cross-sectional analysis. For model development and internal and external validation, 10,044 participants from CHARLS, 3698 from ELSA, and 6884 from the second affiliated hospital of Wenzhou medical university were included. Stacked ML models with optimal obesity indices to detect the risk of stroke were constructed. The predictive accuracy of the models was evaluated with the area under the receiver operating curve (ROC-AUC). Findings: Triglyceride-Glucose-Body Mass Index (TyG-BMI) and TyG were two optimal predictors and outperformed BMI (AUC = 0.821) in the cross-sectional study. In the longitudinal cohort, the model with the highest AUC was the stacked ML model incorporating TyG-BMI, which achieved an AUC of 0.816 (95% CI: 0.807-0.824) in the training cohort and 0.833 (95% CI: 0.816-0.849) in the internal set for predicting stroke risk. For the external sets, the AUC was 0.803 (95% CI: 0.791-0.816) for the ELSA cohort and 0.805 (95% CI: 0.793-0.818) for the health examination cohort. The stacked ML model based on TyG-BMI showed the best performance with the highest F1 score (0.209:0.124:0.117), lowest Brier score (0.040:0.041:0.041) and model improvement (all NRI and IDI >0). The ISS score was significantly associated with stroke and stroke-related death, classifying individuals into low- and high-risk groups for death in the training cohort with and AUC of 0.891 (95% CI: 0.840, 0.935) and 0.879 (95% CI: 0.749, 0.979) for the internal validation sets. Interpretation: The stacked ML model incorporating TyG-BMI effectively predicts stroke risk, with the ISS score demonstrating strong performance across diverse populations. Further research is needed to assess its applicability in broader cohorts. Funding: None.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.